Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 163

1.

Drug discovery for Alzheimer's disease: the end of the beginning.

Refolo LM, Fillit HM.

J Mol Neurosci. 2004;24(1):1-8. No abstract available.

PMID:
15314243
[PubMed - indexed for MEDLINE]
2.

Current and future treatments for Alzheimer's disease.

Salloway S.

CNS Spectr. 2009 Aug;14(8 Suppl 7):4-7; discussion 16-8. Review.

PMID:
19890240
[PubMed - indexed for MEDLINE]
4.

Drug discovery: estrogen-related compounds in mouse models of Alzheimer's disease.

Smith JD, Chakrabarti E, Levin-Allerhand JA.

J Mol Neurosci. 2004;24(1):145-7. Review.

PMID:
15314263
[PubMed - indexed for MEDLINE]
5.

Potassium-retaining diuretics and incident Alzheimer disease.

Reyes AJ.

Arch Neurol. 2006 Oct;63(10):1507. No abstract available.

PMID:
17030675
[PubMed - indexed for MEDLINE]
6.

Molecular mechanisms of ischemic neuronal cell death--with relevance to Alzheimer's disease.

Hayashi T, Shoji M, Abe K.

Curr Alzheimer Res. 2006 Sep;3(4):351-8. Review.

PMID:
17017865
[PubMed - indexed for MEDLINE]
7.

Rethinking Alzheimer's disease: the role of age-related changes.

Drachman DA.

Curr Neurol Neurosci Rep. 2007 Jul;7(4):265-8. Review. No abstract available.

PMID:
17618530
[PubMed - indexed for MEDLINE]
8.

Rosiglitazone effects to ameliorate Alzheimer's disease pathogenic features: insulin signaling and neurotrophic factors.

Castillo-Quan JI.

J Neuropsychiatry Clin Neurosci. 2009 Summer;21(3):347-8. doi: 10.1176/appi.neuropsych.21.3.347. No abstract available.

PMID:
19776322
[PubMed - indexed for MEDLINE]
9.

Nerve growth factor in treatment and pathogenesis of Alzheimer's disease.

Williams BJ, Eriksdotter-Jonhagen M, Granholm AC.

Prog Neurobiol. 2006 Oct;80(3):114-28. Epub 2006 Nov 2. Review.

PMID:
17084014
[PubMed - indexed for MEDLINE]
10.

CNS Targets for multi-functional drugs in the treatment of Alzheimer's and Parkinson's diseases.

Youdim MB, Buccafusco JJ.

J Neural Transm. 2005 Apr;112(4):519-37. Epub 2005 Jan 24. Review.

PMID:
15666041
[PubMed - indexed for MEDLINE]
11.

Targeting the CREB pathway for memory enhancers.

Tully T, Bourtchouladze R, Scott R, Tallman J.

Nat Rev Drug Discov. 2003 Apr;2(4):267-77. Review.

PMID:
12669026
[PubMed - indexed for MEDLINE]
12.

Preservation of the blood brain barrier integrity may underlie neuroprotective effects of statins in Alzheimer's disease.

Ghribi O.

J Alzheimers Dis. 2006 Dec;10(4):407-8. No abstract available.

PMID:
17183152
[PubMed - indexed for MEDLINE]
13.

[The mission and the place of the Academy of Medicine at the onset of the 21st century].

Tubiana M.

Presse Med. 2003 Mar 29;32(12):533-4. French. No abstract available.

PMID:
12714918
[PubMed - indexed for MEDLINE]
14.

What are the prospects of slowing the progression of Alzheimer's disease?

Palmer AM.

Drug Discov Today. 2012 Nov;17(21-22):1157-9. doi: 10.1016/j.drudis.2012.09.009. Epub 2012 Oct 2. No abstract available.

PMID:
23036820
[PubMed - indexed for MEDLINE]
15.

Does statin use decrease the amount of Alzheimer disease pathology in the brain?

Silbert LC.

Neurology. 2007 Aug 28;69(9):E8-11. No abstract available.

PMID:
17724280
[PubMed - indexed for MEDLINE]
16.

A promising new treatment for Alzheimer's disease?

O'Brien JT.

Lancet Neurol. 2008 Sep;7(9):768-9. doi: 10.1016/S1474-4422(08)70177-7. No abstract available.

PMID:
18702997
[PubMed - indexed for MEDLINE]
17.

Incoming academy president message: knowledge is the enemy of disease.

Eger M.

Optom Vis Sci. 2008 Nov;85(11):1030-1. doi: 10.1097/OPX.0b013e31818fbab6. No abstract available.

PMID:
18981917
[PubMed - indexed for MEDLINE]
18.

Neuroprotection: promise and pitfalls in anti-inflammatory treatment of Alzheimer's disease.

Memo M, Blandini F, Nappi G, Spano P.

Funct Neurol. 2002 Oct-Dec;17(4):175-6. No abstract available.

PMID:
12675259
[PubMed - indexed for MEDLINE]
19.

Profile: Richard Lipton: migraines, magnets, and much, much more.

Williams R.

Lancet Neurol. 2008 Dec;7(12):1088. doi: 10.1016/S1474-4422(08)70253-9. No abstract available.

PMID:
19007735
[PubMed - indexed for MEDLINE]
20.

Parkinson's and Alzheimer's diseases: protein aggregations and neuroprotection.

Gozes I.

J Mol Neurosci. 2004;24(3):333-6. No abstract available.

PMID:
15655257
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk